CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Mar 4, 2016
Insider Transaction Report
Form 4
Ren Ken Keyong
Chief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2016-03-02+125,000→ 125,000 totalExercise: $0.88Exp: 2026-03-02→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The stock options vest as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis.